TERBAC IM 1G SOL INY FA-AMP LABORATORIOS ALFASIGMA MEXICO SA DE CV Cáncer de mama HR+ /

Description

Cáncer de mama HR+ / HER2− avanzado o metastásico

Vía de administración: Intravenosa (IV) o subcutánea

30 ML Caja

FORMA FARMACÉUTICA: 40 CAPSULAS

TERBAC IM 1G SOL INY FA-AMP LABORATORIOS ALFASIGMA MEXICO SA DE CV Cáncer de mama HR+ /PRINCIPIO ACTIVO: CEFTRIAXONA

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy